Taipei, Taiwan

Chun-Hung Chou

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Polaris Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Hung Chou. Retrieved from https://idiyas.com/inventor/chun-hung-chou-mjak2ejr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chun-Hung Chou

Introduction

Chun-Hung Chou is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in therapies related to arginine deprivation. His work has implications for various therapeutic strategies, showcasing his innovative approach to solving complex medical challenges.

Latest Patents

Chou holds a patent titled "Methods and Kits for Identifying Subjects Responsive to Arginine Deprivation Therapy." This patent highlights his focus on developing methodologies that can enhance the effectiveness of treatments for specific patient populations. He has 1 patent to his name, reflecting his commitment to advancing medical science.

Career Highlights

Chun-Hung Chou is currently employed at Polaris Pharmaceuticals, Inc., where he continues to engage in groundbreaking research. His role at the company allows him to collaborate with other experts in the field, furthering the development of innovative therapies.

Collaborations

Chou has worked alongside talented colleagues, including Hui-Fen Liu and Hung-Wen Chen. These collaborations have enriched his research and contributed to the advancement of their shared goals in medical innovation.

Conclusion

Chun-Hung Chou exemplifies the spirit of innovation in the medical field through his patent and collaborative efforts. His work at Polaris Pharmaceuticals, Inc. continues to pave the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…